• Principales publications :
  1. Yavchitz A, Boutron I, Bafeta A, Maroun I, Charles P, Mantz J, Ravaud P. Misrepresentation of Randomized Controlled Trials in Press Releases and News Coverage: A Cohort Study. Plos Medicine. 2012; Sep;9(9):e1001308. Epub 2012 Sep 11.
  2. Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012 Feb 27;344:e1119. doi: 10.1136/bmj.e1119.
  3. Bafeta A, Dechartres A, Trinquart L, Yavchitz A, Boutron I, Ravaud P. Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ. 2012 Feb 14;344:e813. doi: 10.1136/bmj.e813
  4. Estellat C, Ravaud P. Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med 2012 Feb 13;172(3):237-44
  5. Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 2011;155(1):39-51
  6. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010; 303(20):2058-64.
  7. Charles P, Giraudeau B, Dechartres A, Baron G, Ravaud P. Reporting of sample size calculation in randomised controlled trials: review. BMJ 2009;12;338:b1732
  8. Giraudeau B, Ravaud P. Preventing bias in cluster randomised trials. PLoS Med 2009;6(5):e1000065
  9. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302(9):977-84
  10. Pibouleau L, Boutron I, Reeves BC, Nizard R, Ravaud P. Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic review. BMJ 2009;339:b4538.
  11. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med 2009;169(19):1756-61
  12. Ravaud P, Flipo RM, Boutron I, Roy C, Mahmoudi A, Giraudeau B, Pham T. ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care forpatients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial. BMJ 2009; 338:b421.
  13. Thabut G, Christie JD, Ravaud P, Castier Y, Dauriat G, Jebrak G, Fournier M, Lesèche G, Porcher R, Mal H. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med 2009; 151(11):767-74.
  14. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, and the Consort Group. Methods and processes of the consort group: the example of an extension for trials assessing non-pharmacological treatments. Ann Intern Med 2008;148:W60-W66.
  15. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P and the Consort Group. Extending the CONSORT statement to randomized trials of non-pharmacological treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309.
  16. Thabut G, Christie JD, Ravaud P, Castier Y, Brugière O, Fournier M, Mal H, Lesèche G, Porcher R. Survival after bilateral lung transplantation versus single lung transplantation for patients with chronic obstructive pulmonary disease. Lancet 2008;371:744-751.
  17. Boutron I, Guittet L,  Estellat C, , Moher D, Hrobjartsson A, Ravaud P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med 2007;4:e61.
  18. Boutron I, Estellat C, Guittet L, Dechartres A, Sackett D, Hrobjartsson A, Ravaud P. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments a systematic review.PLoS Med 2006;3;e425.
  19. Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noninferiority and equivalence randomized trials. JAMA 2006;295:1147-1151.*
  20. Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P. Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease. Ann Intern Med 2005; 143:20-25.
  21. Boutron I, Tubach F, Giraudeau B, Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA 2003; 290:1062-1070.

Les publications de Philippe Ravaud sur PubMed

[download id= »1″]